Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$25.34 - $34.28 $253,400 - $342,800
-10,000 Reduced 23.84%
31,945 $1.03 Million
Q4 2023

May 16, 2024

BUY
$25.21 - $34.66 $252,100 - $346,599
10,000 Added 31.3%
41,945 $1.14 Million
Q3 2023

Nov 13, 2023

SELL
$26.91 - $35.49 $403,650 - $532,350
-15,000 Reduced 26.34%
41,945 $1.25 Million
Q2 2023

Jul 20, 2023

SELL
$25.15 - $32.86 $150,900 - $197,160
-6,000 Reduced 9.53%
56,945 $1.84 Million
Q1 2023

May 11, 2023

SELL
$17.5 - $25.9 $210,962 - $312,224
-12,055 Reduced 16.07%
62,945 $1.63 Million
Q2 2022

Jul 22, 2022

BUY
$14.1 - $20.26 $1.06 Million - $1.52 Million
75,000 New
75,000 $1.19 Million
Q1 2022

May 09, 2022

SELL
$15.23 - $21.47 $2.2 Million - $3.1 Million
-144,403 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$21.65 - $27.0 $3.13 Million - $3.9 Million
144,403 New
144,403 $3.24 Million

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $5.44B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.